Results 121 to 130 of about 313,244 (194)

Novel PE-DT-fusion toxin enhances internalization and target-dependently restores the cytotoxicity of recombinant immunotoxins. [PDF]

open access: yesFront Pharmacol
Fischer C   +7 more
europepmc   +1 more source

Bivalent CD47 Immunotoxin for Targeted Therapy of Lung Cancer. [PDF]

open access: yesBiomedicines
Ma J   +13 more
europepmc   +1 more source

Immunotoxin WPD101a as a Potential Drug Candidate for Targeted Therapy in Muscle Invasive Bladder Cancer Expressing IL-13Rα2-In Vitro Study. [PDF]

open access: yesInt J Mol Sci
Klimczak A   +11 more
europepmc   +1 more source

Development of a diphtheria toxin based antiporcine CD3 recombinant immunotoxin. [PDF]

open access: yesBioconjug Chem, 2011
Wang Z   +8 more
europepmc   +1 more source

Complete Remissions of Adult T-cell Leukemia with Anti-CD25 Recombinant Immunotoxin LMB-2 and Chemotherapy to Block Immunogenicity. [PDF]

open access: yesClin Cancer Res, 2016
Kreitman RJ   +7 more
europepmc   +1 more source

Designing a Novel Immunotoxin against Prostate Cancer based on PE40 Toxin: An <i>In silico</i> Approach. [PDF]

open access: yesAvicenna J Med Biotechnol
Azdoo S   +5 more
europepmc   +1 more source

Recombinant immunotoxin for cancer treatment with low immunogenicity by identification and silencing of human T-cell epitopes. [PDF]

open access: yesProc Natl Acad Sci U S A, 2014
Mazor R   +13 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy